Beijing Balance Medical Technology Co.,Ltd. (SHA: 688198)

Market Cap	17.40B
Revenue (ttm)	405.57M
Net Income (ttm)	103.55M
Shares Out	137.40M
EPS (ttm)	0.76
PE Ratio	166.91
Forward PE	107.35
Dividend	0.80 (0.64%)
Ex-Dividend Date	May 28, 2024

Volume	582,186
Open	126.70
Previous Close	125.88
Day's Range	126.10 - 132.00
52-Week Range	92.55 - 166.00
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About Beijing Balance Medical Technology Co.,Ltd.

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 473
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2023, Beijing Balance Medical Technology Co.,Ltd.'s revenue was 370.64 million, an increase of 25.57% compared to the previous year's 295.17 million. Earnings were 115.21 million, an increase of 21.11%.